Screener
Calidi Biotherapeutics CLDI Q4 2025 Annual earnings
Reported March 27, 2026 · Before market open
EPS-$0.57Beat by $0.99
EPS estimate-$1.56
Next report
Nov 17, 2026 (in 2 months)Versus estimates
Diluted EPS
Q2 2026-$2.94Q1 2026-$0.43
Q4 2025-$0.57Beat by $0.99
Q3 2025-$2.21Miss by $0.53Q2 2025-$1.99Miss by $0.07Q1 2025-$2.16Miss by $2.01FAQ
- When did Calidi Biotherapeutics report Q4 2025 earnings?
- Calidi Biotherapeutics (CLDI) reported Q4 2025 earnings on March 27, 2026 before market open.
- What were Calidi Biotherapeutics's Q4 2025 revenue and EPS?
- Calidi Biotherapeutics reported eps of $-0.57 for Q4 2025.
- Did Calidi Biotherapeutics beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-1.56 by $0.99.
- How did Calidi Biotherapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 11.8% from $-0.51.
- Where can I find Calidi Biotherapeutics's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-26-013236) and the 10-K periodic report (0001493152-26-013242) directly on SEC EDGAR. The filing index links above go to sec.gov.
